Jack Yongfeng Zhang

2021

In 2021, Jack Yongfeng Zhang earned a total compensation of $6.5M as Chief Executive Officer, President, Chief Scientific Officer and Director at Amphastar Pharmaceuticals, a 9% increase compared to previous year.

Compensation breakdown

Bonus$310,847
Non-Equity Incentive Plan$673,000
Option Awards$2,288,518
Salary$898,000
Stock Awards$2,288,490
Other$50,565
Total$6,509,420

Zhang received $2.3M in option awards, accounting for 35% of the total pay in 2021.

Zhang also received $310.8K in bonus, $673K in non-equity incentive plan, $898K in salary, $2.3M in stock awards and $50.6K in other compensation.

Rankings

In 2021, Jack Yongfeng Zhang's compensation ranked 1,929th out of 12,405 executives tracked by ExecPay. In other words, Zhang earned more than 84.4% of executives.

ClassificationRankingPercentile
All
1,929
out of 12,405
84th
Division
Manufacturing
729
out of 5,494
87th
Major group
Chemicals And Allied Products
279
out of 2,369
88th
Industry group
Drugs
238
out of 2,090
89th
Industry
Pharmaceutical Preparations
157
out of 1,537
90th

Pay ratio

Jack Yongfeng Zhang's Pay$6,509,420
Median Employee's Pay$54,552
Pay Ratio

119

to 1

In 2021, the annual total compensation of Jack Yongfeng Zhang was $6,509,420.

The annual total compensation of the median employee at Amphastar Pharmaceuticals was $54,552.

The ratio of Jack Yongfeng Zhang's pay to the pay of median employee was therefore 119 to one.

Source: SEC filing on April 14, 2022.

Zhang's colleagues

We found four more compensation records of executives who worked with Jack Yongfeng Zhang at Amphastar Pharmaceuticals in 2021.

2021

Mary Luo

Amphastar Pharmaceuticals

Chief Operating Officer

2021

William Peters

Amphastar Pharmaceuticals

Chief Financial Officer

2021

Rong Zhou

Amphastar Pharmaceuticals

Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc

2021

Jacob Liawatidewi

Amphastar Pharmaceuticals

Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S

News

You may also like